CDCarlos Dier

Carlos Dier

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Carlos Dier has a total of 89 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Spontaneous regression of post-traumatic syringomyelia: longitudinal mr imaging demonstrating a dynamic disease course

    by Carlos Dier, Charif Sidani, Kevin J. Abrams, Leonardo Furtado Freitas

    Introduction Posttraumatic syringomyelia is a recognized complication of spinal cord injury, often associated with progressive neurologic decline and surgical management. Its natural history remains incompletely understood, and spontaneous resolution is rare. Case presentation We performed a literature review identifying six previously reported cases of spontaneous radiologic resolution of posttraumatic syringomyelia and report a 69-year-old patient with posttraumatic cervicothoracic syringomyelia showing a dynamic course characterized by initial mild enlargement followed by spontaneous radiologic resolution over 13 years of follow-up. Initial MR imaging in 2013 demonstrated a focal expansile syrinx at C7–T1 without enhancement, cerebrospinal fluid flow obstruction, or Chiari malformation. At presentation, the patient reported occipital headaches, dizziness, and subjective upper extremity weakness. Serial MR imaging demonstrated mild interval enlargement in 2019, followed by progressive decrease in 2022 and 2024, and near-complete resolution in 2026, with a residual slit-like cavity and focal cord thinning. Neurologic examinations remained normal throughout follow-up, and symptoms resolved. Discussion This case demonstrates a dynamic course of posttraumatic syringomyelia with spontaneous radiologic resolution and clinical stability in the absence of surgical intervention. These findings suggest that a subset of patients may follow a benign or reversible course, supporting close clinical and imaging follow-up in selected cases.

  • Hemorrhagic sellar lesion mimicking pituitary adenoma apoplexy: MRI follow-up suggesting Rathke cleft cyst

    by Carlos Dier, Charif Sidani, Kevin J. Abrams, Leonardo Furtado Freitas

  • Open Access

    Characterizing clot composition and stroke etiology through hounsfield units

    by Andres Gudino, Carlos Dier, Martin Cabarique, Alexander Van Dam, Alina Rivadeneira-Limongi, Emily Baniewicz, Mario S. Hinojosa-Figueroa, Arshaq Saleem, Divanshu Sharma, Navami Shenoy, et al.

    Purpose: We aimed to analyze clot composition using Hounsfield Units (HU) in non-enhanced computed tomography (NECT). Methods: Thrombi retrieved from mechanical thrombectomy (MT) were imaged on micro-computed tomography (micro-CT) and histologically analyzed. Micro-CT slides were matched to histological sections. Spearman’s rank correlation was performed to correlate micro-CT HU with red blood cells (RBCs) and fibrin composition. A sensitivity analysis was conducted between micro-CT HU and histological slides with > 70% of these components. The same clots were then localized in the pre-MT NECT, and NECT HU values were obtained. Micro-CT HU and NECT HU were correlated for histologically informed interpretation. Receiver operating characteristic analysis was performed to retrieve NECT HU thresholds. A dataset of patients who presented with large vessel occlusion of cardioembolic, large artery atherosclerosis (LAA), and cryptogenic strokes were then assessed through NECT HU. Results: Ten thrombi were analyzed. Micro-CT HU were strongly correlated with histological sections with > 70% of RBCs (Rho 0.675) but not to sections with > 70% of fibrin (Rho 0.325). Micro-CT HU and NECT HU of clots that had > 70% of RBCs were strongly correlated (Rho 0.774). NECT HU of 44 had a sensitivity of 67% and specificity of 86% to determine clots with > 70% of RBCs. A total of 240 NECT images were analyzed including 80 cardioembolic, 80 LAA and 80 cryptogenic strokes. NECT HU assessment showed that 75% of cardioembolic, 40% of LAA and 55% of cryptogenic clots are composed of RBCs. Conclusion: NECT HU is a promising tool to assess clot RBCs composition and infer stroke etiology.

  • Compressive symptoms in fusiform intracranial aneurysms: insights from vessel wall enhancement imaging

    by Carlos Dier, Andres Gudino, Elena Sagues, Navami Shenoy, Martin Andres Cabarique, Shubhangi Setia, Gustavo Chiriboga, Linder Wendt, Chengcheng Zhu, Bing Tian, et al.

    Purpose: Fusiform intracranial aneurysms (FIAs) may cause progressive symptoms due to mass effect on adjacent structures. We quantitatively assessed aneurysm wall enhancement (AWE) in FIAs and its association with compressive symptoms. Methods: We retrospectively analyzed patients with unruptured FIAs who underwent 3T high-resolution MRI at three institutions in the USA and China. Symptomatic status was defined by clinical symptoms with imaging evidence of aneurysm-related mass effect, including cranial neuropathies, non-focal headache associated with aneurysm compression, or hydrocephalus. Three-dimensional AWE maps quantified signal intensity (SI) across the aneurysm wall (3D-AWE) and at focal compressive interfaces (focal AWE). 3D-AWE and focal AWE were compared between symptomatic and asymptomatic FIAs. Logistic regression identified factors associated with symptomatic presentation. Results: Forty-eight patients were included (median age 58 years). Symptomatic FIAs (n=16, 33%) were larger than asymptomatic FIAs (16.3 mm vs 8.6 mm, P=0.001) and showed higher 3D-AWE (1.18 vs 0.82, P<0.001) and focal AWE (1.37 vs 0.92, P=0.009). Independent predictors included female sex (OR 4.58; P=0.027), size (OR 1.38; P=0.002), 3D-AWE (OR 8.17; P=0.002), and focal AWE (OR 24.8; P=0.011). Models incorporating size and AWE yielded AUCs of 0.88 for 3D-AWE and 0.91 for focal AWE. In a subgroup analysis restricted to FIAs ≥10 mm, symptomatic FIAs had greater 3D-AWE (1.22 vs 0.90, P=0.039) and focal AWE (1.25 vs 0.89, P=0.013) than asymptomatic FIAs. Conclusion: FIAs with compressive symptoms had increased 3D-AWE and focal AWE. These features have the potential to be used in the identification of aneurysms that may become symptomatic.

  • Identifying the Symptomatic Aneurysm in Patients With Multiple Intracranial Aneurysms

    by Andres Gudino, Carlos Dier, Sebastian Sanchez, Navami Shenoy, Pablo S. Martinez, Ruben Calle, Domenica Cifuentes, Elena Sagues, Connor Aamot, Bing Zhao, et al.

    BACKGROUND AND OBJECTIVES: Identification of the symptomatic aneurysm in patients with multiple intracranial aneurysms (MIAs) represents a challenge. Aneurysm wall enhancement is a potential imaging biomarker to assess symptomatic status among intracranial aneurysms. We aimed to use aneurysm wall enhancement in the identification of symptomatic aneurysms in patients with MIAs. METHODS: Patients who underwent high-resolution 3 Tesla magnetic resonance imaging between 2018 and 2024 at 3 institutions—one in the United States and 2 in China—were included in the analysis. Eligible patients had MIAs, with at least 1 aneurysm classified as symptomatic. Morphological measurements were obtained from angiography studies. Three-dimensional circumferential aneurysm wall enhancement (3D-CAWE) was assessed for all aneurysms. Multivariate logistic regression was used to identify variables independently associated with symptomatic status. RESULTS: Thirty patients with 82 MIAs were included, 30/82 (36.6%) were symptomatic and 52/82 (63.3%) were asymptomatic. Aneurysmal size (adjusted odds ratio [aOR]: 1.5, 95% CI: 0.95-2.8, P = .1) and size ratio (aOR: 2.2, 95% CI: 0.8-3.2, P = .2) were not associated with symptomatic presentation. Symptomatic aneurysms were more likely to have a higher 3D-CAWE (aOR: 1.15, 95% CI: 1.05-1.24, P = .01) when compared with asymptomatic aneurysms. Receiver operating characteristic analysis revealed that a 3D-CAWE cutoff point of 1.02 has a specificity of 88% and negative predictive value of 79% in detecting symptomatic aneurysms among patients with MIAs. CONCLUSION: 3D-CAWE can be used in the identification of symptomatic aneurysms in patients with MIAs.

  • Stentplasty for treating symptomatic intracranial atherosclerotic disease following failure of medical therapy

    by Carlos Dier, Andres Gudino, Domenica Cifuentes, Ruben Calle, Sebastian Sanchez, Navami Shenoy, Elena Sagues, Connor Aamot, Boris Pabón Guerrero, Mario Zanaty, et al.

    Purpose Endovascular treatment of intracranial atherosclerotic disease (ICAD) remains challenging due to procedural risks and stroke recurrence. Previous trials have favored aggressive medical therapy. In patients refractory to medical therapy, ‘stentplasty’ using expandable and retrievable devices may provide a safer alternative to balloon angioplasty by allowing controlled submaximal vessel dilation without flow arrest. We present a two-center experience using these devices for treating symptomatic ICAD refractory to maximal medical therapy. Methods Patients with symptomatic high-grade stenosis (>70–99%) who failed medical therapy and underwent ‘stentplasty’ with the Tigertriever and Comaneci devices were included. Demographic data, periprocedural complications, and radiological and functional outcomes were evaluated and reported. Results Eighteen patients were treated, of whom 16 (89%) presented with acute ischemic stroke and two (11%) with transient ischemic attacks. The median admission National Institutes of Health Stroke Scale (NIHSS) score was 9 (IQR 6–21). Stentplasty alone resulted in successful reperfusion (modified Thrombolysis in Cerebral Infarction ≥2b–3) in 11 patients (61%); the remaining seven patients (39%) required rescue therapy with permanent stenting. Median stenosis was reduced from 95% (IQR 92–99%) before treatment to 50% (IQR 48–66%) after stentplasty, and further to 10% (IQR 10–19%) in those receiving permanent stents. One periprocedural complication occurred (6%) involving distal embolization. The median (IQR) improvement in NIHSS score from admission to discharge was 5 (0–8) points. No patients experienced recurrent ischemic strokes or reocclusions during follow-up. All achieved a modified Rankin Scale score of 0–2 at 90-day follow-up (range 30–180 days). Conclusion Stentplasty using expandable and retrievable devices appears to be a safe and effective treatment option for patients with symptomatic ICAD refractory to medical therapy. While many cases can be successfully treated with stentplasty alone, a subset may require adjunctive permanent stenting to achieve optimal recanalization.


  • Inter-rater reliability of atherosclerotic plaque enhancement on 7 T vessel wall MRI: Comparison with quantitative analysis

    by Carlos Dier, Sultan Alhajahjeh, Abdallah A Alqudah, Andres Gudino, Navami Shenoy, Martin A Cabarique, Elena Sagues, Sebastian Sanchez, Connor Aamot, Linder Wendt, et al.

    Objective: Intracranial plaque enhancement (IPE) is a potential biomarker of plaque vulnerability but lacks a standardized definition. While subjective assessment may be prone to observer variability, a voxel-based quantification method can detect subtle signal intensity (SI) changes. This study aimed to compare the inter-rater reliability of subjective IPE evaluation with that of a voxel-based quantification method. Methods: Patients with stroke due to intracranial atherosclerosis were prospectively imaged using 7 T vessel wall magnetic resonance imaging. Two adjudicators independently assessed IPE, with discrepancies resolved by a third, experienced neuroradiologist. IPE distribution was quantified using a semiautomated method based on SI measurements from post-contrast T1-weighted images. The mean enhancement ratio was calculated for each plaque to assess gadolinium enhancement. Inter-rater reproducibility and the concordance between subjective and objective assessments were evaluated. Regression analysis was performed to identify plaque morphological features that influenced the reliability of subjective IPE adjudication compared to the objective method. Results: We analyzed 75 plaques from 41 patients. Inter-rater agreement for IPE adjudication was poor ( κ = 0.34). Following consensus, 43% of plaques (32/75) were classified as enhancing, whereas 57% (43/75) were non-enhancing. The agreement between subjective and objective IPE assessments was moderate ( κ = 0.40, p < 0.001). Subjective assessment was more likely to reliably adjudicate IPE for plaques exhibiting >50% stenosis (odds ratio (OR), 1.04; p = 0.02) and a positive remodeling index (OR, 2.20; p = 0.02). In contrast, it was less reliable when evaluating posterior circulation plaques (OR, 0.23; p = 0.01). Conclusion: Subjective assessment of IPE demonstrated poor inter-rater agreement and only moderate concordance with voxel-based quantification following consensus.


  • Open Access

    Correlations between hemodynamics and radiomic features in thrombosed intracranial aneurysms

    by Zonghan Lyu, Andres Gudino, Navami Shenoy, Carlos Dier, Elena Sagues, Jingfeng Jiang, Edgar A Samaniego

    Purpose: Evaluating intracranial aneurysm (IA) rupture risk is essential for guiding management. Although intrasaccular thrombosis (IST) is less common, it can contribute to aneurysm growth, mass effect, and rupture. Aneurysm wall enhancement (AWE) on high-resolution MRI (HR-MRI) offers valuable insight into IST and IA progression. Using radiomics, we extracted spatial information of the aneurysm wall to characterize AWE. This study aimed to explore correlations between radiomics-based AWE profiles and gross hemodynamic parameters, integrating imaging and flow dynamics to better understand IST. Methods: Radiomic analysis was conducted on a cohort of 3T HR-MRI scans from IA with IST. Three-dimensional vascular reconstructions and CFD simulations were conducted to quantify hemodynamic parameters. Spearman’s correlation was performed to correlate aneurysm morphology, AWE patterns, and aneurysmal hemodynamic characteristics. Results: A total of 37 thrombosed IAs were included in the analysis, comprising 22 fusiform (59.5%) and 15 saccular (40.5%) aneurysms. Six AWE RFs demonstrated strong correlations with aneurysm volume and surface area (ρ > 0.7 for both). Ten AWE RFs were highly correlated with flow vortex parameters (ρ > 0.7), and one showed a strong correlation with wall shear stress (WSS)-related metrics (ρ > 0.7). In the subset of saccular IAs, 20 AWE RFs were strongly associated with WSS-related metrics. In contrast, fusiform IAs showed stronger correlations between AWE RFs and vortex core characteristics. These findings suggest that elevated AWE is closely associated with regions of high oscillatory shear index and unstable flow vortices, indicating a potential link between wall enhancement and disturbed intra-aneurysmal hemodynamics. Conclusions Stagnant flow may promote degenerative remodeling of the aneurysm wall and IST. A combined spatiotemporal analysis of hemodynamic parameters and AWE patterns provide information about underlying biological processes of IAs, including the development of IST.


  • Impact of Clinical Variables and Aneurysm Morphology on Hemorrhage Volume and Clinical Outcomes

    by Andres Gudino, Elena Sagues, Carlos Dier, Sebastian Sanchez, Martin Cabarique, Navami Shenoy, Alexander Van Dam, Linder Wendt, Connor Aamot, Santiago Ortega-Gutierrez, et al.

    BACKGROUND AND OBJECTIVES: It is unknown what determines the volume of aneurysmal subarachnoid hemorrhage (aSAH). We aimed to investigate the features associated to the burden of subarachnoid hemorrhage after aneurysm rupture and its impact on clinical outcomes. METHODS: Patients admitted with aSAH between 2009 and 2022 were included. Clinical data were obtained from electronic medical records. Aneurysm location and morphological measurements were assessed using digital subtraction angiography. aSAH volume was objectively quantified on admission noncontrast computed tomography using semiautomated software. Univariate and multivariate analyses were performed to identify predictors of hemorrhage volume and examine its association with delayed cerebral ischemia (DCI), clinical vasospasm, and 7-day mortality in younger (18-64 years) and elderly (≥65 years) patients. RESULTS: Two hundred ruptured intracranial aneurysms were analyzed. Ruptured bifurcating aneurysms exhibited larger hemorrhage volume compared with sidewall aneurysms (23.16 mL, IQR: 34.2 vs 11.95 mL, IQR: 20.9, P = .002). In multivariate analysis, age (exp β 1.02; 95% CI 1.01-1.03; P < .001), Hunt and Hess (exp β 1.46, 95% CI: 1.31-1.62, P <.001), and bifurcation aneurysms (exp β 1.76; 95% CI 1.37-2.26; P <.001) were correlated with increased aSAH volume. Among younger patients, higher aSAH volume was associated with DCI (odds ratio [OR] 1.04; 95% CI 1.02-1.06; P < .001), clinical vasospasm (OR 1.02; 95% CI 1.01-1.03; P = .02), and 7-day mortality (OR 1.05; 95% CI 1.02-1.07; P < .001). In elderly population, larger aSAH was only associated with 7-day mortality (OR 1.04; 95% CI 1.01-1.07; P = .01). CONCLUSION: Older age, bifurcating aneurysms, and higher Hunt and Hess are associated with larger aSAH volumes. In younger patients, greater aSAH volume is linked to an increased risk of DCI, clinical vasospasm, and 7-day mortality. Among older patients, increased aSAH volume is only associated with 7-day mortality.


  • The effect of aspirin on aneurysm wall enhancement: A study in rabbits and humans

    by Elena Sagues, Diego Ojeda, Andres Gudino, Carlos Dier, Navami Shenoy, Arshaq Saleem, Ramanthan Kadiervel, Sebastian Sanchez, Maria B Torres, Vance T Lehman, et al.

    Objective: Aneurysm wall enhancement (AWE) is a potential biomarker of inflammation within the aneurysm wall that has been correlated with a higher risk of rupture. Aspirin (ASA) may decrease AWE due to its anti-inflammatory properties. We aimed to assess the effect of ASA on AWE in an animal model and a cohort of patients with unruptured intracranial aneurysms (UIAs). Methods: Three rabbits with elastase-induced aneurysms were exposed to ASA for 8 weeks and three rabbits were used as controls. 3 T high-resolution magnetic resonance imaging (HR-MRI) was performed at 7 days and 8 weeks to evaluate changes in AWE through histological and immunohistological analyses. Additionally, we evaluated AWE in patients who underwent imaging with a 3 T HR-MRI protocol. ASA exposure was defined as daily intake of 81 mg for at least six months prior to HR-MRI. AWE was quantified using three-dimensional AWE maps and histograms. Results: Among rabbits exposed to ASA, the mean AWE was lower at 8 weeks compared to the controls (2.11 vs 2.15, p = 0.13). Immunostaining of the aneurysm wall in rabbits that received ASA revealed a reduced expression of CD68 + or cyclooxygenase-2 + cells, compared to the controls. A total of 99 patients with 120 UIAs were included in the HR-MRI analysis of UIAs. UIAs exposed to ASA (22/120) had significantly lower median AWE than those that were not exposed (0.60 vs 0.72, p = 0.032). Conclusion: ASA therapy is associated with an objective reduction in AWE, suggesting a potential role in lowering the risk of aneurysm rupture.